A Family-Based Alcohol Preventive Intervention for Latino Emerging Adults
Abstract
The purpose of the proposed study was to develop a family-based drinking prevention intervention for Latino emerging adults (EAs) and Latino parents of EAs. Although drinking rates for Latinos are lower than those for Whites in terms of the prevalence of alcohol use, the consequences of alcohol use (e.g., drunk driving, unplanned/unprotected sex, alcohol-related injuries) appear to be more severe for Latinos, especially those 18-23 years old. The investigators developed a brief (4 session) intervention for each of EAs and parents focused on identity development and parent support for EAs, respectively.
Conditions: Binge Alcohol Consumption, Risk Behavior, Health, Driving Under the Influence, High-Risk Sex, Identity, Social, Parenting.
Primary outcome: Emerging Adult Self-Efficacy; Parent-Emerging Adult Relationship Quality; Parent Trust in Emerging Adult Decision-Making; Parent support; Emerging adult alcohol consumption; Drinking-related risk behaviors; Drinking-related harm reduction behaviors; Emerging adult perceived stress; Parent perceived stress; Bicultural identity integration; Emerging adult future orientation; Parent hope for emerging adult child's future; American identity integration.
Enrollment: 83 participants.
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 83 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.